• Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Arg486His (c.1457G>A); ClinVar=VCV000809472; Zygosity=Unspecified (PubMed=33128777).
  
• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=33128777).
  
• Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Pro300Leu (c.899C>T); Zygosity=Unspecified (PubMed=33128777).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Unspecified (PubMed=33128777).
  

PubMed=26956206; DOI=10.5966/sctm.2015-0214; PMCID=PMC4798739
De Angelis M.L., Zeuner A., Policicchio E., Russo G., Bruselles A., Signore M., Vitale S., De Luca G., Pilozzi E., Boe A., Stassi G., Ricci-Vitiani L., Amoreo C.A., Pagliuca A., Francescangeli F., Tartaglia M., De Maria R., Baiocchi M.
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance.
Stem Cells Transl. Med. 5:511-523(2016)

PubMed=27286453; DOI=10.18632/oncotarget.9859; PMCID=PMC5190083
Signore M., Buccarelli M., Pilozzi E., De Luca G., Cappellari M., Fanciulli M., Goeman F., Melucci E., Biffoni M., Ricci-Vitiani L.
UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
Oncotarget 7:44113-44128(2016)

PubMed=33128777; DOI=10.1002/ijc.33370; PMCID=PMC7894552
Visconti P., Parodi F., Parodi B., Casarino L., Romano P., Buccarelli M., Pallini R., D'Alessandris Q.G., Montori A., Pilozzi E., Ricci-Vitiani L.
Short tandem repeat profiling for the authentication of cancer stem-like cells.
Int. J. Cancer 148:1489-1498(2021)